Satoshi Omiya
Overview
Explore the profile of Satoshi Omiya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
14
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gon H, Omiya S, Komatsu S, Yamasaki N, Murakami S, Fukushima K, et al.
Langenbecks Arch Surg
. 2025 Jan;
410(1):34.
PMID: 39794665
Purpose: This study aimed to evaluate the efficacy of indocyanine green (ICG)-fluorescence imaging for the identification of hepatic boundaries during liver resection and its advantages in surgical outcomes over conventional...
2.
Fujisawa A, Komatsu S, Omiya S, Fujinaka R, Yamasaki N, Yanagimoto H, et al.
Anticancer Res
. 2024 Jul;
44(8):3349-3353.
PMID: 39060053
Background/aim: Neskeep, an absorbable polyglycolic acid spacer, has been developed as the optimal material for spacer placement surgery. However, preventing its severe adhesion is a crucial concern. Therefore, we aimed...
3.
Gon H, Komatsu S, Omiya S, Kido M, Fukushima K, Urade T, et al.
Anticancer Res
. 2024 Apr;
44(5):2031-2038.
PMID: 38677757
Background/aim: This study aimed to evaluate the utility of the albumin-bilirubin grade for predicting the prognosis after repeat liver resection for patients with recurrent hepatocellular carcinoma. Patients And Methods: Ninety...
4.
Koizumi A, Komatsu S, Omiya S, Yano Y, Fujishima Y, Ishida J, et al.
Anticancer Res
. 2024 Apr;
44(5):2055-2061.
PMID: 38677746
Background/aim: The treatment algorithm for systemic therapies for advanced hepatocellular carcinoma (HCC) has changed dramatically; however, the therapeutic landscape for sequential second-line or later-line treatments, including ramucirumab, remains controversial. This...
5.
Fujinaka R, Komatsu S, Terashima K, Demizu Y, Omiya S, Kido M, et al.
Radiat Oncol
. 2023 Oct;
18(1):173.
PMID: 37875956
Background: Spacer placement surgery is useful in particle therapy (PT) for patients with abdominopelvic malignant tumors located adjacent to the gastrointestinal tract. This study aimed to assess the safety, efficacy,...
6.
Omiya S, Urade T, Komatsu S, Kido M, Kuramitsu K, Yanagimoto H, et al.
HPB (Oxford)
. 2023 Sep;
25(12):1555-1565.
PMID: 37684130
Background: The Global Leadership Initiative on Malnutrition (GLIM), comprising several of the major global clinical nutrition societies, suggested the world's first criteria for diagnosis of the severity of malnutrition. However,...
7.
Okazoe Y, Omiya S, Nakajima T, Kishi A, Kido M, Suzuki S, et al.
Kobe J Med Sci
. 2023 Sep;
69(2):E52-E56.
PMID: 37661703
Background: Synchronous isolated external iliac lymph node metastasis of ascending colon cancer is extremely rare, and its treatment strategy has not been established. In this report, we present a case...
8.
Masuda S, Yamakawa K, Masuda A, Toyama H, Sofue K, Nanno Y, et al.
Ann Surg Oncol
. 2023 May;
30(9):5776-5787.
PMID: 37191859
Background: Sarcopenia, defined as a loss of skeletal muscle mass and quality, is found in 30-65% of patients with pancreatic ductal adenocarcinoma (PDAC) at diagnosis, and is a poor prognostic...
9.
Okazoe Y, Yanagimoto H, Tsugawa D, Akita M, Asakura R, Omiya S, et al.
Anticancer Res
. 2023 Apr;
43(5):2299-2308.
PMID: 37097645
Background/aim: Recently, the Global Leadership Initiative on Malnutrition (GLIM), which includes the world's leading clinical nutrition societies, proposed the first global diagnostic criteria for malnutrition. However, the association between malnutrition...
10.
Nakagawa D, Komatsu S, Yano Y, Kido M, Kuramitsu K, Yamamoto A, et al.
Anticancer Res
. 2023 Jan;
43(2):911-918.
PMID: 36697097
Background/aim: The chemotherapeutic landscape for hepatocellular carcinomas (HCCs) has changed dramatically with the availability of several treatment options. This study aimed to assess the long-term outcomes of lenvatinib treatment and...